Skip to main content

Arrhythmias in the Athlete

  • Chapter
  • First Online:
Management of Cardiac Arrhythmias

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

Cardiac arrhythmias in the absence of underlying structural heart disease and cardiovascular conditions predisposing to arrhythmias represent a unique challenge for the clinician. Despite comprehensive evaluation, uncertainty frequently remains regarding management and athletic participation. Pre-participation screening strategies have many limitations in identifying cardiovascular conditions that predispose to life-threatening arrhythmias with exercise. Since screening strategies for detecting and preventing sudden death on the athletic field have not been shown to have sufficient sensitivity, specificity, and cost-effectiveness, it is likely that initial manifestation of cardiovascular conditions predisposing to sudden death will continue to be cardiac arrest in a considerable number of athletes. Based on this, recommendations for automatic external defibrillation, training in cardiopulmonary resuscitation, and an emergency response planning have been developed for athletic activities. Guidance is also available to clinicians regarding evaluation, management, and athletic participation of arrhythmias in athletes. Most commonly, clinical judgment and experience, rather than evidence, are the basis of these recommendations for therapy and athletic participation. The cardiovascular conditions predisposing to arrhythmias and the arrhythmias that can occur in the absence of any structural heart disease in the athlete are reviewed in this chapter from multiple perspectives. These include clinical evaluation of the athlete with arrhythmias, screening strategies for cardiovascular conditions that predispose to arrhythmias, and guidelines for athletic participation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995;27(5):641–7.

    PubMed  Google Scholar 

  2. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296(13):1593–601.

    CAS  PubMed  Google Scholar 

  3. Holst AG, Winkel BG, Theilade J, et al. Incidence and etiology of sports-related sudden cardiac death in Denmark--implications for preparticipation screening. Heart Rhythm. 2010;7(10):1365–71.

    PubMed  Google Scholar 

  4. Solberg EE, Gjertsen F, Haugstad E, Kolsrud L. Sudden death in sports among young adults in Norway. Eur J Cardiovasc Prev Rehabil. 2010;17(3):337–41.

    PubMed  Google Scholar 

  5. Roberts WO, Stovitz SD. Incidence of sudden cardiac death in Minnesota high school athletes 1993-2012 screened with a standardized pre-participation evaluation. J Am Coll Cardiol. 2013;62(14):1298–301.

    PubMed  Google Scholar 

  6. Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol. 2014;63(16):1636–43.

    PubMed  Google Scholar 

  7. Harmon KG, Zigman M, Drezner JA. The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: a systematic review/meta-analysis. J Electrocardiol. 2015;48(3):329–38.

    PubMed  Google Scholar 

  8. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119(8):1085–92.

    PubMed  Google Scholar 

  9. Steinvil A, Chundadze T, Zeltser D, et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol. 2011;57(11):1291–6.

    PubMed  Google Scholar 

  10. Marijon E, Tafflet M, Celermajer DS, et al. Sports-related sudden death in the general population. Circulation. 2011;124(6):672–81.

    PubMed  Google Scholar 

  11. Drezner JA, Harmon KG, Marek JC. Incidence of sudden cardiac arrest in Minnesota high school student athletes: the limitations of catastrophic insurance claims. J Am Coll Cardiol. 2014;63(14):1455–6.

    PubMed  Google Scholar 

  12. Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence and etiology of sudden cardiac arrest and death in high school athletes in the United States. Mayo Clin Proc. 2016;91(11):1493–502.

    PubMed  Google Scholar 

  13. Emery MS, Kovacs RJ. Sudden cardiac death in athletes. JACC Heart Fail. 2018;6(1):30–40.

    PubMed  Google Scholar 

  14. Zipes DP, Link MS, Ackerman MJ, Kovacs RJ, Myerburg RJ, Estes NA 3rd. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e315–25.

    PubMed  Google Scholar 

  15. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e256–61.

    PubMed  Google Scholar 

  16. Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 2: preparticipation screening for cardiovascular disease in competitive athletes: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2356–61.

    PubMed  Google Scholar 

  17. Link MS, Myerburg RJ, Estes NA 3rd. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 12: emergency action plans, resuscitation, cardiopulmonary resuscitation, and automated external defibrillators: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e334–8.

    PubMed  Google Scholar 

  18. Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273–80.

    PubMed  Google Scholar 

  19. Thompson PD, Myerburg RJ, Levine BD, Udelson JE, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 8: coronary artery disease: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e310–4.

    PubMed  Google Scholar 

  20. Corrado D, Wichter T, Link MS, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Eur Heart J. 2015;36(46):3227–37.

    PubMed  PubMed Central  Google Scholar 

  21. Estes NAM 3rd, Madias C. Atrial fibrillation in athletes: a lesson in the virtue of moderation. JACC Clin Electrophysiol. 2017;3(9):921–8.

    PubMed  Google Scholar 

  22. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2019;16(8):e66–93.

    PubMed  Google Scholar 

  23. Smith ML, Hudson DL, Graitzer HM, Raven PB. Exercise training bradycardia: the role of autonomic balance. Med Sci Sports Exerc. 1989;21(1):40–4.

    CAS  PubMed  Google Scholar 

  24. Baldesberger S, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2008;29(1):71–8.

    PubMed  Google Scholar 

  25. Serra-Grima R, Puig T, Donate M, Gich I, Ramon J. Long-term follow-up of bradycardia in elite athletes. Int J Sports Med. 2008;29(11):934–7.

    CAS  PubMed  Google Scholar 

  26. Senturk T, Xu H, Puppala K, et al. Cardiac pauses in competitive athletes: a systematic review examining the basis of current practice recommendations. Europace. 2016;18(12):1873–9.

    PubMed  Google Scholar 

  27. Sharma S, Whyte G, Elliott P, et al. Electrocardiographic changes in 1000 highly trained junior elite athletes. Br J Sports Med. 1999;33(5):319–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Stein R, Medeiros CM, Rosito GA, Zimerman LI, Ribeiro JP. Intrinsic sinus and atrioventricular node electrophysiologic adaptations in endurance athletes. J Am Coll Cardiol. 2002;39(6):1033–8.

    PubMed  Google Scholar 

  29. Zeppilli P, Fenici R, Sassara M, Pirrami MM, Caselli G. Wenckebach second-degree A-V block in top-ranking athletes: an old problem revisited. Am Heart J. 1980;100(3):281–94.

    CAS  PubMed  Google Scholar 

  30. Talan DA, Bauernfeind RA, Ashley WW, Kanakis C Jr, Rosen KM. Twenty-four hour continuous ECG recordings in long-distance runners. Chest. 1982;82(1):19–24.

    CAS  PubMed  Google Scholar 

  31. Ogawa S, Tabata H, Ohishi S, et al. Prognostic significance of long ventricular pauses in athletes. Jpn Circ J. 1991;55(8):761–6.

    CAS  PubMed  Google Scholar 

  32. Hood S, Northcote RJ. Cardiac assessment of veteran endurance athletes: a 12 year follow up study. Br J Sports Med. 1999;33(4):239–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Magalski A, McCoy M, Zabel M, et al. Cardiovascular screening with electrocardiography and echocardiography in collegiate athletes. Am J Med. 2011;124(6):511–8.

    PubMed  Google Scholar 

  34. Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(5):516–24.

    PubMed  Google Scholar 

  35. Estes NAM 3rd, Link MS, Cannom D, et al. Report of the NASPE Policy Conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol. 2001;12(10):1208–19.

    PubMed  Google Scholar 

  36. Ector H, Bourgois J, Verlinden M, et al. Bradycardia, ventricular pauses, syncope, and sports. Lancet. 1984;2(8403):591–4.

    CAS  PubMed  Google Scholar 

  37. Viitasalo MT, Kala R, Eisalo A. Ambulatory electrocardiographic recording in endurance athletes. Br Heart J. 1982;47(3):213–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Bjornstad H, Storstein L, Meen HD, Hals O. Ambulatory electrocardiographic findings in top athletes, athletic students and control subjects. Cardiology. 1994;84(1):42–50.

    CAS  PubMed  Google Scholar 

  39. Yerg JE 2nd, Seals DR, Hagberg JM, Ehsani AA. Syncope secondary to ventricular asystole in an endurance athlete. Clin Cardiol. 1986;9(5):220–2.

    PubMed  Google Scholar 

  40. Milstein S, Buetikofer J, Lesser J, et al. Cardiac asystole: a manifestation of neurally mediated hypotension-bradycardia. J Am Coll Cardiol. 1989;14(7):1626–32.

    CAS  PubMed  Google Scholar 

  41. Karadag B, Aliyev F, Duman D, Ongen Z, Vural VA. Post-exercise cardiac asystole in persons without underlying heart disease: management and follow-up of three cases. J Cardiovasc Med (Hagerstown). 2007;8(10):855–8.

    Google Scholar 

  42. Ito M, Hasegawa K, Arakawa M, Chinushi M. Post-exercise cardiac asystole in a young competitive athlete. Intern Med. 2012;51(8):979.

    PubMed  Google Scholar 

  43. Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2019;16(9):e128–226.

    PubMed  Google Scholar 

  44. Meytes I, Kaplinsky E, Yahini JH, Hanne-Paparo N, Neufeld HN. Wenckebach A-V block: a frequent feature following heavy physical training. Am Heart J. 1975;90(4):426–30.

    CAS  PubMed  Google Scholar 

  45. Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2009;11(1):11–7.

    PubMed  Google Scholar 

  46. Aizer A, Gaziano JM, Cook NR, Manson JE, Buring JE, Albert CM. Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol. 2009;103(11):1572–7.

    PubMed  PubMed Central  Google Scholar 

  47. Furlanello F, Bertoldi A, Dallago M, et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol. 1998;9(8 Suppl):S63–8.

    CAS  PubMed  Google Scholar 

  48. Malhotra A, Dhutia H, Finocchiaro G, et al. Outcomes of cardiac screening in adolescent soccer players. N Engl J Med. 2018;379(6):524–34.

    PubMed  Google Scholar 

  49. Sharma S, Drezner JA, Baggish A, et al. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J. 2018;39(16):1466–80.

    PubMed  Google Scholar 

  50. Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010;31(2):243–59.

    PubMed  Google Scholar 

  51. Uberoi A, Stein R, Perez MV, et al. Interpretation of the electrocardiogram of young athletes. Circulation. 2011;124(6):746–57.

    PubMed  Google Scholar 

  52. Pfister GC, Puffer JC, Maron BJ. Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA. 2000;283(12):1597–9.

    CAS  PubMed  Google Scholar 

  53. Paterick TE, Paterick TJ, Fletcher GF, Maron BJ. Medical and legal issues in the cardiovascular evaluation of competitive athletes. JAMA. 2005;294(23):3011–8.

    CAS  PubMed  Google Scholar 

  54. Estes NAM 3rd, Link MS, Homoud M. Electrocardiographic variants and cardiac rhythm and conduction disturbances in the athlete. In: Thompson PD, editor. Exercise and sports cardiology. New York: McGraw-Hill; 2001. p. 211–32.

    Google Scholar 

  55. Williams ES, Owens DS, Drezner JA, Prutkin JM. Electrocardiogram interpretation in the athlete. Herzschrittmacherther Elektrophysiol. 2012;23(2):65–71.

    CAS  PubMed  Google Scholar 

  56. Pelliccia A, Maron BJ, Di Paolo FM, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005;46(4):690–6.

    PubMed  Google Scholar 

  57. Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 10: the cardiac channelopathies: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e326–9.

    PubMed  Google Scholar 

  58. Drezner JA, Courson RW, Roberts WO, Mosesso VN, Link MS, Maron BJ. Inter-association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. J Athl Train. 2007;42(1):143–58.

    PubMed  PubMed Central  Google Scholar 

  59. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91–220.

    PubMed  Google Scholar 

  60. Lampert R, Olshansky B, Heidbuchel H, et al. Safety of sports for athletes with implantable cardioverter-defibrillators: long-term results of a prospective multinational registry. Circulation. 2017;135(23):2310–2.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. A. Mark Estes III .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

McEnteggart, S., Bhonsale, A., Link, M.S., Mark Estes, N.A. (2020). Arrhythmias in the Athlete. In: Yan, GX., Kowey, P., Antzelevitch, C. (eds) Management of Cardiac Arrhythmias. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-41967-7_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41967-7_27

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-41966-0

  • Online ISBN: 978-3-030-41967-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics